FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019916355> ?p ?o ?g. }

• W2019916355 endingPage "239" @default.
• W2019916355 startingPage "239" @default.
• W2019916355 abstract "Abstract. Objectives. We studied the association of clopidogrel with mortality in acute myocardial infarction (AMI) patients with heart failure (HF) not receiving percutaneous coronary intervention (PCI). Background. Use of clopidogrel after AMI is low in patients with HF, despite the fact that clopidogrel is associated with absolute mortality reduction in AMI patients. Methods. All patients hospitalized with first-time AMI (2000 through 2005) and not undergoing PCI within 30 days from discharge were identified in national registers. Patients with HF treated with clopidogrel were matched by propensity score with patients not treated with clopidogrel. Similarly, 2 groups without HF were identified. Risks of all-cause death were obtained by the Kaplan–Meier method and Cox regression analyses. Results. We identified 56,944 patients with first-time AMI. In the matched cohort with HF (n=5050) and a mean follow-up of 1.50 years (SD=1.2), 709 (28.1%) and 812 (32.2%) deaths occurred in patients receiving and not receiving clopidogrel treatment, respectively (P=.002). The corresponding numbers for patients without HF (n=6092), with a mean follow-up of 2.05 years (SD=1.3), were 285 (9.4%) and 294 (9.7%), respectively (P=.83). Patients with HF receiving clopidogrel demonstrated reduced mortality (hazard ratio, 0.86; 95% confidence interval, 0.78–0.95) compared with patients with HF not receiving clopidogrel. No difference was observed among patients without HF (hazard ratio, 0.98; 95% confidence interval, 0.83–1.16). Conclusions. Clopidogrel was associated with reduced mortality in patients with HF who do not undergo PCI after their first-time AMI, whereas this association was not apparent in patients without HF. Further studies of the benefit of clopidogrel in patients with HF and AMI are warranted.—Bonde L, Sorensen R, Fosbol EL, et al. Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study. J Am Coll Cardiol. 2010;55:1300–1307." @default.
• W2019916355 created "2016-06-24" @default.
• W2019916355 creator A5065345564 @default.
• W2019916355 creator A5079359898 @default.
• W2019916355 creator A5087670438 @default.
• W2019916355 date "2010-07-28" @default.
• W2019916355 modified "2023-10-18" @default.
• W2019916355 title "Increased Mortality Associated With Low Use of Clopidogrel in Patients With Heart Failure and Acute Myocardial Infarction Not Undergoing Percutaneous Coronary Intervention" @default.
• W2019916355 doi "https://doi.org/10.1111/j.1751-7133.2010.00173.x" @default.
• W2019916355 hasPublicationYear "2010" @default.
• W2019916355 type Work @default.
• W2019916355 sameAs 2019916355 @default.
• W2019916355 citedByCount "0" @default.
• W2019916355 crossrefType "journal-article" @default.
• W2019916355 hasAuthorship W2019916355A5065345564 @default.
• W2019916355 hasAuthorship W2019916355A5079359898 @default.
• W2019916355 hasAuthorship W2019916355A5087670438 @default.
• W2019916355 hasBestOaLocation W20199163551 @default.
• W2019916355 hasConcept C126322002 @default.
• W2019916355 hasConcept C164705383 @default.
• W2019916355 hasConcept C207103383 @default.
• W2019916355 hasConcept C2777849778 @default.
• W2019916355 hasConcept C2778198053 @default.
• W2019916355 hasConcept C2780400711 @default.
• W2019916355 hasConcept C44249647 @default.
• W2019916355 hasConcept C45393284 @default.
• W2019916355 hasConcept C500558357 @default.
• W2019916355 hasConcept C50382708 @default.
• W2019916355 hasConcept C71924100 @default.
• W2019916355 hasConcept C72563966 @default.
• W2019916355 hasConceptScore W2019916355C126322002 @default.
• W2019916355 hasConceptScore W2019916355C164705383 @default.
• W2019916355 hasConceptScore W2019916355C207103383 @default.
• W2019916355 hasConceptScore W2019916355C2777849778 @default.
• W2019916355 hasConceptScore W2019916355C2778198053 @default.
• W2019916355 hasConceptScore W2019916355C2780400711 @default.
• W2019916355 hasConceptScore W2019916355C44249647 @default.
• W2019916355 hasConceptScore W2019916355C45393284 @default.
• W2019916355 hasConceptScore W2019916355C500558357 @default.
• W2019916355 hasConceptScore W2019916355C50382708 @default.
• W2019916355 hasConceptScore W2019916355C71924100 @default.
• W2019916355 hasConceptScore W2019916355C72563966 @default.
• W2019916355 hasIssue "5" @default.
• W2019916355 hasLocation W20199163551 @default.
• W2019916355 hasOpenAccess W2019916355 @default.
• W2019916355 hasPrimaryLocation W20199163551 @default.
• W2019916355 hasRelatedWork W2355614377 @default.
• W2019916355 hasRelatedWork W2375232986 @default.
• W2019916355 hasRelatedWork W2375584960 @default.
• W2019916355 hasRelatedWork W2378890344 @default.
• W2019916355 hasRelatedWork W2380518343 @default.
• W2019916355 hasRelatedWork W2382579536 @default.
• W2019916355 hasRelatedWork W2414025265 @default.
• W2019916355 hasRelatedWork W2595368886 @default.
• W2019916355 hasRelatedWork W2782203991 @default.
• W2019916355 hasRelatedWork W3029448752 @default.
• W2019916355 hasVolume "16" @default.
• W2019916355 isParatext "false" @default.
• W2019916355 isRetracted "false" @default.
• W2019916355 magId "2019916355" @default.
• W2019916355 workType "article" @default.